Radiohalogenation of Proteins: An Overview of Radionuclides, Labeling Methods and Reagents for Conjugate Labeling

Bioconjugate Chemistry

Volumn 3, Issue 6, 1992, Pages 433-470

  Wilbur, D Scott ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; HALOGEN; PROTEIN; RADIOISOTOPE;

ANIMAL; CHEMISTRY; FORECASTING; HUMAN; REVIEW;

ANIMALS; FORECASTING; HALOGENS; HUMANS; INDICATORS AND REAGENTS; PROTEINS; RADIOISOTOPES;

EID: 0026951113     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc00018a001     Document Type: Article

References (353)

1. Magerstadt, M. (1991) Antibody Conjugates and Malignant Disease, pp 11-35, 79-93, CRC Press, Boca Raton, FL.
2. Osterman, L. A. (1984) Labeling of Proteins. Methods of Protein and Nucleic Acid Research, pp 131-143, Springer-Verlag, New York.
3. Kas, J., and Rauch, P. (1983) Labeled Proteins, Their Preparation and Applications. Topics in Current Chemistry (F. L. Boschke, Ed.) Vol. 112, pp 167-182, Springer-Verlag, NY.
4. Srivastava, S. C., Ed. (1988) Radiolabeled Monoclonal Antibodies for Imaging and Therapy, Part III, pp 193-268, Plenum Press, New York.
5. Regoeczi, E., Ed. (1984) Iodine-labeled Plasma Proteins, Vols. I and II, CRC Press, Inc., New York.
6. Eckelman, W. C., Paik, C. H., and Reba, R. C. (1980) Radiolabeling of Antibodies. Cancer Res. 40, 3036-3042.
7. Fritzberg, A. R., Berninger, R. W., Hadley, S. W., and Wester, D. W. (1988) Approaches to Radiolabeling of Antibodies for Diagnosis and Therapy of Cancer. Pharm. Res. 5, 325-334.
8. Fine, J., and Seligman, A. M. (1943) Traumatic Shock: IV. A Study of the Problem of the“Lost Plasma”in Hemorrhagic Shock by the Use of Radioactive Plasma Protein. J. Clin. Invest. 22, 285-303.
9. Li, C. H. (1945) Iodination of Tyrosine Groups in Serum Albumin and Pepsin. J. Am. Chem. Soc. 67, 1065-1069.
10. Pressman, D., and Keighley, G. (1948) The Zone of Activity of Antibodies as Determined by the Use of Radioactive Tracers; The Zone of Activity of Nephritoxic Antikidney Serum. J. Immunol. 59, 141-146.
11. Bale, W. F., and Spar, I. L. (1957) Studies Directed Toward the Use of Antibodies as Carriers of Radioactivity for Therapy. Adv. Biol. Med. Phys. 5, 285-356.
12. Bolton, A. E., and Hunter, W. M. (1986) Radioimmunoassay and related methods. Handbook of Experimental Immunology: Immunochemistry, Volume 1 4th ed. (D. M. Weir, Ed.), pp 26.1-26.56, Blackwell Scientific Publications, London, England.
13. Bolton, A. E. (1985) Selection of a Suitable Radioisotope. Radioiodination Techniques, 2nd ed., pp 14-15, Amersham Corp., Arlington Heights, IL.
14. Berson, S. A., Yalow, R. S., Bauman, A., Rothschild, A., and Newerly, K. (1956) Insulin-I131 Metabolism in Human Subjects: Demonstration of Insulin Binding Globulin in the Circulation of Insulin Treated Subjects. J. Clin. Invest. 35, 170-190.
15. Yalow, R. S., and Verson, S. A. (1960) Immunoassay of Endogenous Plasma Insulin in Man. J. Clin. Invest. 39, 1157-1175.
16. Argentini, M. (1982) Labelling of Proteins and Peptides. Labelling with Iodine. A Review of the Literature, pp 255-285, Swiss Federal Institute for Reactor Research, Wueren-lingen, Switzerland (ISBN 3-85677-005-4).
17. Eary, J. F., Krohn, K. A., Kishore, R., and Nelp, W. B. (1989) Radiochemistry of Halogenated Antibodies. Antibodies in Radiodiagnosis and Therapy (M. R. Zalutsky, Ed.) pp 83102, CRC Press, Inc., Boca Raton, FL.
18. Regoeczi, E. (1984) Methods of Protein Iodination. Iodine-labeled Plasma Proteins, Vol. I, pp 35-102, CRC Press, Inc., New York.
19. Knight, L. C., Krohn, K. A., Welch, M. J., Spomer, B. and Hager, L. P. (1975) 77Br: A New Protein Label. Radiopharmaceuticals (G. Subramanian, B. A. Rhodes, J. F. Cooper, and V. J. Sodd, Eds.) pp 149-154, The Society of Nuclear Medicine, New York.
20. McElvany, K. D., Barnes, J. W., and Welch, M. J. (1980) Characterization of Bromine-77-Labeled Proteins Using Myeloperoxidase. Int. J. Appl. Radiat. Isot. 31, 679-688.
21. McElvany, K. D., and Welch, M. J. (1980) Characterization of Bromine-77-Labeled Proteins Prepared Using Bromoper-oxidase. J. Nucl. Med. 21, 953-960.
22. Hughes, W. L., and Gitlin, D. (1954) The Reaction of Astatine with Protein. USAECD-BNL- 314, p 48.
23. Hughes, W. L., and Gitlin, D. (1955) Astatinated (At211) organic compounds for production of highly localized radiobiological effects. Am. Soc. Biol. Chem. 229 (abstract).
24. Aaij, C., Tschroots, W. R. J. M., Lindner, L., and Feltkamp, T. E. W. (1978) The Preparation of Astatine Labeled Proteins. Int. J. Appl. Radiat. Isot. 26, 25-30.
25. Vaughan, A. T. M., and Fremlin, J. H. (1978) The Preparation of Astatine Labeled Proteins Using an Electrophilic Reaction. Int. J. Nucl. Med. Biol. 5, 229-230.
26. Visser, G. W. M., Diemer, E. L., Vos, C. M., and Kaspersen, F. M. (1981) The Biological Behavior of Some Organic Astatine Compounds in Rats. Int. J. Appl. Radiat. Isot. 32, 913-917.
27. Visser, G. W. M., Diemer, E. L., and Kaspersen, F. M. (1981) The Nature of the Astatine-Protein Bond. Int. J. Appl. Radiat. Isot. 32, 905-912.
28. Quaim, S. M., and Stocklin, G. (1983) Production of Some Medically Important Short-Lived Neutron-Deficient Radioisotopes of Halogens. Radiochim. Acta 34, 25-40.
29. Kleinberg, J., and Cowan, G. A. (1960) The Radiochemistry of Fluorine, Chlorine, Bromine, andlodine, National Academy of Sciences, National Research Council Nuclear Science Series, Office of Technical Services, Department of Commerce, Washington, DC.
30. Yano, Y. (1975) Radionuclide Generators: Current and Future Applications in Nuclear Medicine. Radiopharmaceuticals (G. Subramanian, B. A. Rhodes, J. F. Cooper, and V. J. Sodd, Eds.) pp 236-245, The Society of Nuclear Medicine, New York.
31. Lambrecht, R. M. (1983) Radionuclide Generators. Radiochim. Acta 34, 9-24.
32. Ruth, T. J., Pate, B. D., Robertson, R., and Porter, J. K. Radionuclide Production for the Biosciences. Nucl. Med. Biol. 16, 323-336.
33. Waters, S. L., and Silvester, D. J. (1982) Inorganic Cyclotron Radionuclides. Radiochim. Acta 30, 163-173.
34. Grant, P. M., Whipple, R. E., Barnes, J. W., Bentley, G. E., Wanek, P. M., and O'brien, H. A. (1981) The Production and Recovery of 77Br at Los Alamos for Nuclear Medicine Studies. J. Inorg. Nucl. Chem. 43, 2217-2222.
35. Kirby, H. W. (1985) Production, Isolation, and Purification of Astatine Isotopes. Gmelin Handbook of Inorganic Chemistry, Astatine, 8th ed. (H. K. Kugler, and C. Keller, Eds.) pp 95-106, Springer-Verlag, New York.
36. Kilboum.M.R. (1990) Production of Fluorine-18. Fluorine-18 Labeling of Radiopharmaceuticals, pp 4-14, National Academy of Sciences, National Science Council Nuclear Science Series (NAS-NS-3203), National Academy Press, Washington, DC.
37. Schafer, D. E. (1983) Measurement of Receptor-Ligand Binding: Theory and Practice. Lecture Notes in Biomathematics: Tracer Kinetics and Physiologic Modeling (R. M. Lambrecht, and A. Rescigno, Eds.) pp 445-507, Springer-Verlag, New York.
38. Wagner, H. N. (1989) SNM Highlights-1989: Why Not? J. Nucl. Med. 30, 1283-1295.
39. Wagner, H. N. (1990) Scientific Highlights 1990: The Universe Within. J. Nucl. Med. 31, 17A-26A.
40. Wagner, H. N. (1991) Molecular Medicine: From Science to Service. J. Nucl. Med. 32, 11N-23N.
41. Consensus Panels (1985) The Developing Role of ShortLived Radionuclides in Nuclear Medicine Practice (P. Paras, and J. W. Thiessen, Eds.) pp 497-544, Office of Scientific and Technical Information, United States Department of Energy, Conf-830523 (DE82008258).
42. McElvany, K. D., Katzenellenbogen, J. A., Shafer, K. E., Siegel, B. A., Senderoff, S. G., Welch, M. J., and the Los Alamos Medical Research Group (1982) 16α-[77Br]Bromoestradiol: Dosimetry and Preliminary Clinical Studies. J. Nucl. Med. 23, 425-430.
43. Welch, M. J., and Kilbourn, M. R. (1986) Clinical Potential of Positron-Emitting Radiopharmaceuticals. Radiopharmaceuticals, Progress and Clinical Perspectives, Vol. II, pp 115-125, CRC Press, Inc., Boca Raton, FL.
44. Barrio, J. R., Hawkins, R. A., Mazziotta, J. C., and Phelps, M. E. (1986) Biochemical Strategies in Positron Emission Tomography. Current Applications in Radiopharmacology. Proceedings of the Fourth International Symposium on Radiopharmacology. (M. W. Billinghurst, Ed.) pp 2-16, Pergamon Press, New York.
45. Pentlow, K. S., Graham, M. C., Lambrecht, R. M., Cheung, N.-K.V., and Larson, S. M. (1991) Quantitative imaging of 1-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy. Med. Phys. 18, 357-366.
46. DeLand, F. H., and Goldenberg, D. M. (1986) Radiolabeled Antibodies: Radiochemistry and Clinical Applications. Freeman and Johnson's Clinical Radionuclide Imaging, 3rd ed., pp 1915-1992, Grune and Stratton, Inc., New York.
47. Lyster, D. M., and Alcorn, L. N. (1986) Antibody Imaging and Therapy in Human Cancer. In Radiopharmaceuticals: Progress and Clinical Perspectives (A. R. Fritzberg, Ed.) Vol. 1, pp 41-59, CRC Press, Inc., Boca Raton, FL.
48. Cobb, L. M., and Humm, J. L. (1986) Radioimmunotherapy of malignancy using antibody targeted radionuclides. Br. J. Cancer 54, 863-870.
49. Buchsbaum, D. J., and Lawrence, T. S. (1991) Tumor Therapy with Radiolabeled Monoclonal Antibodies. Antibody, Immunoconjugate Radiopharm. 4, 245-272.
50. Wessels, B. W., and Rogus, R. D. (1984) Radionuclide Selection and Model Absorbed Dose Calculations for Radiolabeled Tumor Associated Antibodies. Med. Phys. 11, 638-645.
51. Troutner, D. E. (1987) Chemical and Physical Properties of Radionuclides. Nucl. Med. Biol. 14, 171-176.
52. Wolf, W., and Shani, J. (1986) Criteria for Selection of the Most Desirable Radionuclide for Radiolabeling Monoclonal Antibodies. Nucl. Med. Biol. 13, 319-324.
53. Humm, J. L. (1986) Dosimetric Aspects of Radiolabeled Antibodies for Tumor Therapy. J. Nucl. Med. 27, 1490-1497.
54. Brown, I. (1986) Astatine Radiopharmaceuticals. Astatine-211: Its Possible Applications in Cancer Therapy. Appl. Radiat. Isot. 37, 789-798.
55. Wilbur, D. S. (1991) Potential Use of Alpha Emitting Radionuclides in the Treatment of Cancer. Antibody, Immunoconjugate Radiopharm. 4, 85-97.
56. Kassis, A. I., Adelstein, S. J., and Bloomer, W. D. (1987) Therapeutic Implications of Auger-Emitting Radionuclides. Radionuclides in Therapy (R. P. Spencer, R. H. Seevers, and A. M. Friedman, Eds.) pp 119-134, CRC Press, Inc., Boca Raton, FL.
57. Bender, H., Emrich, J., Glennon, P., Steplewski, Z., and Brady, L. W. (1992) Pharmacokinetic behavior and microdosimetry of 125I-labeled α-epidermal growth factor receptor MAb 425 in human glioma cell in vitro. Antibody, Immunoconjugate Radiopharm. 5, 129 (abstract).
58. Bender, H., Morabito, M., Emrich, Rackover M., Miyamoto, C., Woo, D. V., Steplewski, Z., and Brady, L. W. (1992) Pharmacokinetic behavior of 125I-labeled α-epidermal growth factor receptor MAb 425 in high grade glioma patients. Antibody, Immunoconjugate Radiopharm. 5, 130 (abstract).
59. Veall, N., Pearson, J. D., and Hanley, T. (1955) The Preparation of 132I and 131I Labelled Human Serum Albumin for Clincal Tracer Studies. Br. J. Radiol. 28, 633-636.
60. De Kok, J., Van Den Hamer, C. J. A., and Goeij, J. J. M. (1990) Iodine-129 as a Protein Label for Studies of Plasma Protein Turnover and its Measurement with Neutron Activation Analysis. Nucl. Med. Biol. 17, 303-307.
61. de la Mare, P. B. D. (1976) Electrophilic Halogenation. Cambridge University Press, Cambridge, England.
62. Friedman, A. M., and Huang, C. C. (1983) Halogen Labeled Compounds. Radiotracers for Medical Applications (G. V. S. Rayudu, Ed.) Vol. I, pp 219-261, CRC Press, Inc., Boca Raton, FL.
63. Seevers, R. H., and Counsell, R. D. (1982) Radioiodination Techniques for Small Organic Molecules. Chem. Rev. 82, 575-590.
64. Murray, A., and Williams, D. L. (1958) Isotopic Halogen Compounds. Organic Synthesis with Isotopes, Part 2, pp 1147-1177, Interscience Publishers, Inc., New York.
65. Spicer, J. A., Preston, D. F., Robinson, R. G., Bradshaw, D. L., Stern, S. H., Dean, R. D., Martin, N. L., and Rhodes, B. A. (1977) A Case for 77-Bromine Labelled Radiopharmaceuticals. Int. J. Appl. Radiat. Isot. 28, 163-168.
66. Eakins, M. N., and Waters, S. L. (1979) The Synthesis of 77Br-labelled 5α-Dihydrotestosterone and a Comparison of Its Distribution in Rats with 77-Bromide. Int. J. Appl. Radiat. Isot. 30, 701-703.
67. McElvany, K. D., Welch, M. J., Katzenellenbogen, J. A., Senderoff, S. G., Bentley, G. E., and Grant, P. M. (1981) Scope and Limitations of a Rapid Radiobromination Technique. Int. J. Appl. Radiat. Isot. 32, 411-416.
68. Malcolme-Lawes, D. J., and Massey, S. (1981) The Preparation of Radiobromine-Labelled Compounds. J. Radioanal. Chem. 64, 281-290.
69. Kulmala, H. K., Huang, C. C., Dinerstein, R. J., and Freidman, A. M. (1981) Specific In Vivo Binding of 77Br-p-Bromospiroperidol in Rat Brain: A Potential Tool for Gamma Ray Imaging. Life Sci. 28, 1911-1916.
70. Doran, D. M., and Spar, I. L. (1980) Oxidative Iodine Monochloride Iodination Technique. J. Immunol. Methods 39, 155-163.
71. Greenwood, F. C., Hunter, M. W., and Glover, J. S. (1963) The Preparation of 131I-Labelled Human Growth Hormone of High Specific Radioactivity. Biochem. J. 89, 114-123.
72. Salacinski, P. R. P., McLean, C., Sykes, J. E. C., Clement-Jones, V. V., and Lowry, P. J. (1981) Iodination of Proteins, Glycoproteins, and Peptides Using a Solid-Phase Oxidizing Agent, l, 3, 4, 6-Tetrachloro-3α, 6α-diphenyl Glycoluril (Iodogen). Anal. Biochem. 117, 136-146.
73. Markwell, M. A. K. (1982) A New Solid-State Reagent to Iodinate Proteins. I. Conditions for the Efficient Labeling of Antiserum. Anal. Biochem. 125, 427-432.
74. Hadi, U. A. M., Malcolme-Lawes, J., and Oldham, G. (1979) Rapid Radiohalogenations of Small Molecules-II. Radiobromination of Tyrosine, Uracil, and Cytosine. Int. J. Appl. Radiat. Isot. 30, 709-712.
75. Mazaitis, J. K., Francis, B. E., Eckelman, W. C., Gibson, R. E., Reba, R. C., Barnes, J. W., Bentley, G. E., Grant, P. M., and O'brien, H. A. (1981) No-Carrier-Added Bromination of Estrogens with Chloramine-T and Na77Br. J. Labelled Compd. Radiopharm. 18, 1033-1038.
76. Petzold, G., and Coenen, H. H. (1981) Chloramine-T for“No-Carrier-Added”Labelling of Aromatic Biomolecules with Bromine-75, 77. J. Labelled Compd. Radiopharm. 18, 1319-1336.
77. Youfeng, H., Coenen, H. H., Petzold, G., and Stocklin, G. (1982) A Comparative Study of Radioiodination of Simple Aromatic Compounds via N-Halosuccinimides and Chloramine-T in TFAA. J. Labelled Compd. Radiopharm. 19, 807-819.
78. Coenen, H. H., Moerlein, S. M., and Stocklin, G. (1983) No-Carrier-Added Radiohalogenation Methods with Heavy Halogens. Radiochim. Acta 34, 47-68.
79. Zalutsky, M. R., and Narula, A. S. (1987) An Improved Method for the Radiohalogenation of Monoclonal Antibodies. Immunological Approaches to the Diagnosis and Therapy of Breast Cancer (R. L. Ceriani, Ed.) pp 187-203, Plenum Press, New York.
80. Zalutsky, M. R., and Narula, A. S. (1988) Astatination of Proteins using an N-Succinimidyl Tri-n-Butylstannyl Benzoate Intermediate. Appl. Radiat. Isot. 39, 227-232.
81. Wilbur, D. S., Hadley, S. W., Hylarides, M. D., Abrams, P. G., Beaumier, P. L., Morgan, A. C., Reno, J., and Fritzberg, A. R. (1989) Development of a Stable Radioiodinating Reagent to Label Monoclonal Antibodies For Radiotherapy of Cancer. J. Nucl. Med. 30, 216-226.
82. Wilbur, D. S., and Hylarides, M. D. (1991) Radiolabeling of A Monoclonal Antibody with N-Succinimidyl para-[77Br]-Bromobenzoate. Nucl. Med. Biol. 18, 363-365.
83. Hadley, S. W., Wilbur, D. S., Gray, M. A., and Atcher, R. W. (1991) Astatine-211 Labeling of an Anti-Melanoma Antibody and its ' Fab Fragment using iV-Succinimidyl p-[211At] Astatobenzoate: Comparisons in vivo with thep-[125I]-Iodobenzoyl Conjugate. Bioconjugate Chem. 2, 171-179.
84. Wilbur, D. S., and Anderson, K. W. (1982) Bromine Chloride from N-Chlorosuccinimide Oxidation of Bromide Ion. Electrophilic Addition Reactions in Protic and Aprotic Solvents. J. Org. Chem. 47, 358-359.
85. Wilbur, D. S., and O'brien, H. A. (1982) A-Ring Bromination of Estradiol and 17α-Ethynylestradiol with N-Chlorosuccin-imide and Bromide Ion. J. Org. Chem. 47, 359-362.
86. Wilbur, D. S., Anderson, K. W., Stone, W. E., and O'brien, H. A. (1982) Radiohalogenation of Non-activated Aromatic Compounds Via Aryltrimethylsilyl Intermediates. J. Labelled Compd. Radiopharm. 19, 1171-1187.
87. Coenen, H. H., Machulla, H.-J., and Stocklin, G. (1979) Practically Carrier-Free Labeling of Aromatic Compounds with Bromine-77 via N-Chloro-Tetrafluorosuccinimide. J. Labelled Compd. Radiopharm. 16, 891-907.
88. Coenen, H. H., Petzold, G., and Stocklin, G. (1982) Recent Studies of Radiobromination and -Iodination (NCA) with Chloramine-T and Dichloramine-T in Aqueous and Organic Solvents. J. Labelled Compd. Radpharm. 19, 1580-1581 (abstract).
89. Karonen, S.-L., Morsky, P., Siren, M., and Seuderling, U. (1975) An Enzymatic Solid-Phase Method for Trace Iodination of Proteins and Peptides with 125Iodine. Anal. Biochem. 67, 1-10.
90. Goldenberg, D. M., Goldenberg, H., Sharkey, R. M., Higginbotham-Ford, E., Lee, R. E., Swayne, L. C., Burger, K. A., Tsai, D., Horowitz, J. A., Hall, T. C., Pinsky, C. M., and Hansen, H. J. (1990) Clinical Studies of Cancer Radioimmunodetection with Carcinoembryoinic Antigen Monoclonal Antibody Fragments Labeled with 123I Cancer Res. 50, 909s-921s.
91. Pant, K.D., Zamora, P.O., Sass, K.S., Stewart, T.A., Valdez, E. F., O'rourke, A. T., and Shah, V. O. (1987) A Comparison of Monoclonal Antibodies Against Distinct Colon Tumor-Associated Antigens in Immunohistochemistry and in Tumor Localization. Nucl. Med. Biol. 14, 81-89.
92. Bianco, J.A., Brown, P. A., Durack, L., Badger, C., Bernstein, I., Eary, J., Durham, J., Fisher, D., Sandmaier, B., Schuening, F., Storb, R., and Appelbaum, F. R. (1990) Effects of Propylthiouracil on Biodistribution of an Iodine-131-Labeled Anti-Myeloid Antibody in Normal Dogs: Dosimetry and Clinical Implications. J. Nucl. Med. 31, 1384-1389.
93. Sakahara, H., Endo, K., Nakashima, T., Koizumi, M., Kunimatsu, M., Kawamura, Y., Ohta, H., Nakamura, T., Tanaka, H., Kotoura, Y., Yamamuro, T., Hosoi, S., Toyama, S., and Torizuka, S. (1987) Localization of Human Osteogenic Sarcoma Xenografts in Nude Mice by a Monoclonal Antibody Labeled with Radioiodine and Indium-111. J. Nucl. Med. 28, 342-348.
94. Wahl, R. L., Geatti, O., Liebert, M., Wilson, B., Shreve, P., and Beers, B. A. (1987) Kinetics of Interstitially Administered Monoclonal Antibodies for Purposes of Lymphoscintigraphy. J. Nucl. Med. 28, 1736-1744.
95. Carrasquillo, J. A., Sugarbaker, P., Colcher, D., Reynolds, J. C., Estaban, J., Bryant, G., Keenan, A. M., Perentesis, P., Yokoyama, K., Simpson, D. E., Ferroni, P., Farkas, R., Schlom, J., and Larson, S. M. (1988) Radioimmunoscintigraphy of Colon Cancer with Iodine-131-Labeled B72.3 Monoclonal Antibody. J. Nucl. Med. 29, 1022-1030.
96. Buraggi, G. L., Callegaro, L., Mariani, G., Turrin, A., Cascinelli, N., Attili, A., Bombardieri, E., Terno, G., Plassio, G., Dovis, M., Mazzuca, N., Natali, P. G., Scassellati, G. A., Rosa, U., and Ferrone, S. (1985) Imaging with 131I-Labeled Monoclonal Antibodies to a High-Molecular-Weight Melanoma-associated Antigen in Patients with Melanoma: Efficacy of Whole Immunoglobulin and its F(ab')2 Fragments. Cancer Res. 45, 3378-3387.
97. Munz, D. L., Alavi, A., Koprowski, H., and Herlyn, D. (1986) Improved Radioimmunoimaging of Human Tumor Xenografts by a Mixture of Monoclonal Antibody F(ab')2 Fragments. J. Nucl. Med. 27, 1739-1745.
98. Bolton, A. E. (1985) Appendix I. Experimental Protocols for the Radioiodination of Proteins and Other Compounds. Radioiodination Techniques, 2nd ed., pp 58-59. Amersham Corp., Arlington Heights, IL.
99. March, J. (1985) Aromatic Electrophilic Substitution. Advanced Organic Chemistry, pp 447-511, John Wiley & Sons, New York.
100. Regoeczi, E. (1984) Reactivities of Amino Acids and Proteins with Iodine. Iodine-labeled Plasma Proteins, Vol. I, pp 127-213, CRC Press, Inc., New York.
101. Knight, L. C., and Welch, M. J. (1978) Sites of Direct and Indirect Halogenation of Albumin. Biochim. Biophys. Acta 543, 185-195.
102. Hughes, W.L. (1957) The Chemistry of Iodination. Ann. N.Y. Acad. Sci. 20, 3-18.
103. Hughes, W. L., and Gitlin, D. (1955) Astatinated (At211) Organic Compounds for Production of Highly Localized Radiobiological Effects. Am. Soc. Biol. Chem. 14, 229.
104. Vaughan, A. T. M., and Fremlin, J. H. (1977) The Preparation of Astatotyrosine. Int. J. Appl. Radiat. Isot. 28, 595-598.
105. Visser, G. W. M., Diemer, E. L., and Kaspersen, F. M. The Preparation and Stability of Astatotyrosine and Astato-iodotyrosine. Int. J. Appl. Radiat. Isot. 30, 749-752.
106. Regoeczi, E. (1987) In Vivo Behavior of Catabolized Labels Derived from Iodoproteins. Iodine-labeled Plasma Proteins, Vol. II, Part B, pp 43-71, CRC Press, Inc., New York.
107. Engler, D., and Burger, A. G. (1984) The Deiodination of the Iodothyronines and of Their Derivatives in Man. Endocr. Rev. 5, 151-184.
108. Sinsheimer, J. E., Wang, T., Roder, S., and Shum, Y. Y. Mechanisms for the Biodehalogenation of Iodocom-pounds. Biochem. Biophys. Res. Commun. 83, 281-286.
109. Gerstenberger, M. R. C., and Haas, A. (1981) Methods of Fluorination in Organic Chemistry. Angew. Chem., Int. Ed. Engl. 20, 647-667.
110. Schlosser.M. (1978) Introduction ofFluorine into Organic Molecules: Why and How. Tetrahedron 34, 3-17.
111. Rozen, S., and Filler, R. (1985) α-Fluorocarbonyl Compounds and Related Chemistry. Tetrahedron 41, 1111-1153.
112. Hewitt, C. D., and Silvester, M. J. (1988) Fluoroaromatic Compounds: Synthesis, Reactions and Commerical Applications. Aldrichimica Acta 21, 3-10.
113. Palmer, A. J., Clark, J. C., and Goulding, R. W. (1977) The Preparation of Fluorine-18 Labelled Radiopharmaceuticals. Int. J. Appl. Radiat. Isot. 28, 53-65.
114. Tewson.T. J. (1982) Organic Synthesis Involving Fluorine-18. Applications of Nuclear and Radiochemistry (R. M. Lambrecht and N. Morcos, Eds.) pp 163-183, Pergamon Press, New York.
115. Fowler, J. S., and Wolf, A. P. (1982) The Synthesis of Carbon-11, Fluorine-18, and Nitrogen-13 Labeled Radiotracers for Biomedical Applications, National Academy of Sciences, National Research Council Nuclear Science Series-Nuclear Medicine, NAS-NS-3201 (DE82014870).
116. Kilbourn, M. R. (1990) Methods of [18F]Fluorination. Fluorine-18 Labeling of Radiopharmaceuticals, pp 15-69, National Academy of Sciences, National Science Council Nuclear Science Series (NAS-NS-3203), National Academy Press, Washington, DC.
117. Brown, H. C., and Stock, L. M. (1957) Relative Rates of Bromination of Benzene and Methylbenzenes. Partial Rate Factors for the Bromination Reaction. J. Am. Chem. Soc. 79, 1421-1425.
118. Brown, H. C., and Stock, L. M. (1957) Relative Rates of Chlorination of Benzene, Toluene, and the Xylenes. Partial Rate Factors for the Chlorination Reaction. J. Am. Chem. Soc. 79, 5175-5179.
119. Braendlin, H. P., and McBee, E. T. (1964) Halogenation. Friedel-Crafts and Related Reactions (G. A. Olah, Ed.) Vol. III, Part 2, pp 1517-1593, Interscience Publishers, New York.
120. Baird, W.C., and Surridge, J. H. (1970) Halogenation with Copper(II) Halides. The Synthesis of Aryl Iodides. J. Org. Chem. 35, 3436-3442.
121. Sugita, T., Idei, M., Ishibasha, I. Y., and Takegami, Y. (1982) Aromatic Iodination with Aluminum and Copper(II) Chlorides and Iodine. Chem. Lett. 1481-1482.
122. Radner, F. (1988) Lower Nitrogen Oxide Species as Catalysts in a Convenient Procedure for the Iodination of Aromatic Compounds. J. Org. Chem. 53, 3548-3553.
123. Pagni, R. M., Kabalka, G. W., Boothe, R., Gaetano, K., Stewart, L. J., Conaway, R., Dial, C., Gray, D., Larson, S., and Luidhardt, T. (1988) Reactions of Unsaturated Compounds with Iodine and Bromine on y Alumina. J. Org. Chem. 53, 4477-4482.
124. Kahn, S. A., Munawar, M. A., and Siddiq, M. (1988) Monobromination of Deactivated Active Rings Using Bromine, Mercuric Oxide, and Strong Acid. J. Org. Chem. 53, 1799-1800.
125. Zollinger, H. (1978) Nitrogen as Leaving Group: Dediazoniations of Aromatic Diazonium Ions. Angew. Chem., Int. Ed. Engl. 17, 141-150.
126. Hodgson, H. H. (1947) The Sandmeyer Reaction. Chem. Rev. 40, 251-277.
127. Merkushev, E. B. (1988) Advances in the Synthesis of Iodoaromatic Compounds. Synthesis 923-937.
128. Visser, G. W. M., and Diemer, E. L. (1982) The Reaction of Astatine with Aromatic Diazonium Compounds. Radiochem. Radioanal. Lett. 51, 135-141.
129. Meyer, G.-J., Rossler, K., and Stocklin, G. (1979) Reaction of Aromatic Diazonimum Salts with Carrier-Free Radioiodine and Astatine. Evidence for Complex Formation. J. Am. Chem. Soc. 101, 3121-3123.
130. Hughes, W. L., and Klinenberg, J. (1955) Astatine (At211) Incorporation into Aromatic Nuclei Via Diazonium Compounds. USAECD-BNL- 367, pp 42-43.
131. Tewson, T. J., and Welch, M. J. (1979) Preparation of Fluorine-18 Aryl Fluorides: Piperidyl Triazines as a Source of Diazonium Salts. J. Chem. Soc., Chem. Commun. 1149-1150.
132. Foster, N. I., Heindel, N. D., Burns, H. D., and Muhr, W. Aryl Iodides from Anilines via Triazine Intermediates. Synthesis 572-573.
133. Foster, N. I., Dannals, R., Burns, H. D., and Heindel, N. D. (1981) A Condition Variation Study for Radioiodination via Triazine Intermediates. J. Radioanal. Chem. 65, 95-105.
134. Satyamurthy, N., Barrio, J. R., Schmidt, D. G., Kammerer, C., Bida, G. T., and Phelps, M. E. (1990) Acid-Catalyzed Thermal Decomposition of 1-Aryl-3, 3-dialkyltriazines in the Presence of Nucleophiles. J. Org. Chem. 55, 4560-4564.
135. Bunnett, J. F., and Yijima, C. (1977) Thermolysis of Arenediazonium Ions in Acidic Methanol: Evidence for Competing, Independent Ionic and Radical Mechanisms. J. Org. Chem. 42, 639-643.
136. Broxton, T. J., Bunnett, J. F., and Paik, C. H. (1977) Thermolysis of Arenediazonium Salts in Acidic Methanol. Effects of Substituents, Atmospheres, and Added Substances on the Competition between Ionic and Radical Mechanisms. J. Org. Chem. 42, 643-649.
137. Gilliland, D. L., Basmadjian, G. P., Marchand, A. P., Hinkle, G. H., Earlywine, A., and Ice, R. D. (1981) Iodine Labeled Pharmaceuticals from Arylthallium Bis(Trifluoroacetate) Intermediate. J. Radioanal. Chem. 65, 107-113.
138. Brown, I., and Mitchell, J. S. (1979) 6-[125I]-Iodo-2-methyl-1, 4-naphthoquinol Bis(diammonium phosphate): A New Potential Anti-tumour Drug. J. Chem. Soc., Chem. Commun. 659-660.
139. Flanagan, R. J., Charleson, P. P., and Synnes, E. I. (1985) Radiolabeling with Organomercury Compounds, Part 1. The Synthesis and Structure of 6-Halocholest-5-en-3/5-ols. Can. J. Chem. 63, 2853-2860.
140. Visser, G. W. M., Diemer, D. L., and Kaspersen, F. M. (1979) The Preparation of Aromatic Astatine Compounds Through Aromatic Mercury-Compounds. J. Labelled Compd. Radiopharm. 17, 657-665.
141. Visser, G. W. M., Bakker, C. N. M., v. Halteren, B. W., Herscheid, J. D. M., Brinkman, G. A., and Hoekstra, A. (1986) Fluorination and Fluorodemercuration of Aromatic Compounds with Acetyl Hypofluorite. J. Org. Chem. 51, 1886-1889.
142. Kabalka, G. W. (1984) Incorporation of Stable and Radioactive Isotopes via Organoborane Chemistry. Acc. Chem. Res. 17, 215-221.
143. Seitz, D. E., Tonnensen, G. L., Heilman, S., Hanson, R. N., and Adelstein, S. J. (1980) Iododestannylation. Position-specific Synthesis of Iodotamoxifen. J. Organomet. Chem. 186, C33-C36.
144. Coleman, R. S., Seevers, R. H., and Friedman, A. M. (1982) Aromatic Radiobromination without Added Carrier. J. Chem. Soc., Chem. Commun. 1276-1277.
145. Adam, J. J., Ruth, R. J., Homma, Y., and Pate, B. D. (1985) Radiobromination of Aromatic Compounds by Cleavage of Aryl-tin Bonds. Int. J. Appl. Radiat. Isot. 36, 935-937.
146. Milius, R. A., McLaughlin, W. H., Lambrecht, R. M., Wolf, A. P., Carrol, J. J., Adelstein, S. J., and Bloomer, W. D. (1986) Organoastatine Chemistry. Astatination via Electrophilic Destannylation. Appl. Radiat. Isot. 37, 799-802.
147. Hanson, R. N., Franke, L., Lee, S.-H., and Seitz, D. E. (1987) Radioiododestannylation: Preparation and Evaluation of Radioiodinated Thienyl Alcohols. Appl. Radiat. Isot., Part A 38, 641-645.
148. Wilbur, D. S., Anderson, K. W., Stone, W. E., and O'brien, H. A. (1982) Radiohalogenation of Non Activated Aromatic Compounds via Aryltrimethylsilyl Intermediates. J. Labelled Compd. Radiopharm. 19, 1171-1188.
149. Speranza, M., Shuie, C. Y., Wolf, A. P., Wilbur, D. S., and Angelini, G. (1985) Electrophilic Radiofluorination of Aryltrimethylsilanes as a General Route to F-18 Labelled Arylfluorides. J. Fluorine Chem. 30, 97-107.
150. Wilbur, D. S., Stone, W. E., and Anderson, K. W. (1983) Regiospecific Incorporation of Bromine and Iodine into Phenols Using Trimethylsilylphenol Derivatives. J. Org. Chem. 48, 1542-1544.
151. Wilbur, D. S., and Svitra, Z. V. (1984) Electrophilic Radiobrominations of Hippuric Acid: An Example of the Utility of Aryltrimethylsilane Intermediates. J. Labelled Compd. Radiopharm. 21, 415-428.
152. Di Raddo, P., Diksic, M., and Jolly, D. (1984) The 18F Radiofluorination of Arylsilanes. J. Chem. Soc., Chem. Commun. 159-160.
153. Wilson, A. A., Dannals, R. F., Ravert, H. T., Burns, H. D., and Wagner, H. N. (1985) 1-125 and 1-123 Labeled Iodobenzyl Bromide, A Useful Alkylating Agent for Radiolabeling Biologically Important Molecules. J. Labelled Compd. Radiopharm. 23, 83-93.
154. Wilson, S. R., and Jacob, L. A. (1986) Iodination of Aryltrimethylsilanes: A Mild Approach to Iodophenylalanine. J. Org. Chem. 51, 4833-4836.
155. Wilbur, D. S., and Svitra, Z. V. (1983) Organopentafluo-rosilicates. Reagents for Rapid and Efficient Incorporation of No-Carrier-Added Radiobromine and Radioiodine. J. Labelled Compd. Radiopharm. 20, 619-626.
156. Speranza, M., Shiue, C. Y., Wolf, A. P., Wilbur, D. S., and Angelini, G. (1984) Regiospecific Radiofluorination of Aryl-pentafluorosilicates as a General Route to F-18-Labelled Arylfluorides. J. Chem. Soc. Chem. Commun. 1448-1449.
157. Moerlein, S. M. (1985) Regiospecific Incorporation of NoCarrier-Added Radiobromine and Radioiodine into Aromatic Rings via Halogendegermylation. J. Chem. Soc., Perkin Trans. 1 1687-1692.
158. Moerlein, S. M. (1987) Use of Aryltrimethylgermanium Substrates for Facile Aromatic Chlorination, Bromination, and Iodination. J. Org. Chem. 52, 664-667.
159. Kabalka, G. W., and Varma, R. S. (1989) The Synthesis of Radiolabeled Compounds via Organometallic Intermediates. Tetrahedron 45, 6601-6621.
160. Moerlein, S. M., Mathis, C. A., and Yano, Y. (1987) Comparative Evaluation of Electrophilic Aromatic Iodode-metailation Techniques for Labeling Radiopharmaceuticals with Iodine-122. Appl. Radiat. Isot., Part A 38, 85-90.
161. Hylarides, M. D., Wilbur, D. S., Hadley, S. W., and Fritzberg, A. R. (1989) Synthesis and Iodination of Methyl 4-Tri-n-Butylstannylbenzoate, 4-Carbomethoxyphenyl Mercuric Chloride and 4-Carbomethoxyphenyl Boronic Acid. J. Organomet. Chem. 367, 259-265.
162. Wilbur, D. S., Hylarides, M. D., and Fritzberg, A. R. (1989) Reactions of Organometallic Compounds with Astatine-211. Application to Protein Labeling. Radiochim. Acta 47, 137- 142.
163. Grayson, E. J., and Whitham, G. H. (1988) Addition of Iodine-Based Electrophilic Reagent to Some Vinyl Silanes. Tetrahedron 44, 4087-4094.
164. Kabalka, G. W., Gooch, E. D., and Hsu, H. C. (1981) A Convenient Procedure for the Synthesis of Vinyl Iodides via the Reaction of Iodine Monochloride with Vinylboronic Acid. Synth. Commun. 11, 247-251.
165. Kabalka, G. W., Gooch, E. E., Hsu, H. C., Washburn, L. C., Sun, T. T., and Hayes, R. L. (1982) Rapid and Mild Synthesis of Radioiodinated Estrogen Derivatives via Orga-noborane Technology. Applications of Nuclear and Radiochemistry (R. M. Lambrecht, and M. Morcos, Eds.) pp 197- 203, Pergamon Press, New York.
166. Hanson, R. N., Seitz, D. E., and Bottaro, J. C. (1984) Radiohalodestannylation: Synthesis of 125I-Labeled 17α-E-Iodovinylestradiol. Int. J. Appl. Radiat. Isot. 35, 810-812.
167. Hanson, R. N., El-Wakil, H., Murphy, F., and Wilbur, D. S. (1989) Synthesis and Evaluation of 82Br and 77Br Labeled (17, 20J5)-21-bromo-19-norprena-l, 3, 5(10), 20-tetraene-3, 17-diol. J. Labelled Compd. Radiopharm. 27, 615-627.
168. DeSombre, E. R., Hughes, A., Mease, R., and Harper, P. V. (1990) Comparison of the Distribution of Bromine-77 Bromovinyl Steroidal and Triphenylethylene Estrogens in the Immature Rat. J. Nucl. Med. 31, 1534-1542.
169. Chi, D. Y., Kiesewetter, D. O., Katzenellenbogen, J. A., Kilbourn, M. R., and Welch, M. J. (1986) Halofluorination of Olefins: Elucidation of Reaction Characteristics and Applications in Labeling with the Positron-Emitting Radionuclide Fluorine-18. J. Fluorine Chem. 31, 99-113.
170. Means, G. E., and Feeney, R. E. (1990) Chemical Modification of Proteins: History and Applications. Bioconjugate Chem. 1, 2-12.
171. Feeney, R. E., Yamasaki, R. B., and Geoghegan, K. F. (1982) Chemical Modification of Proteins: An Overview. Modification of Proteins. Food, Nutritional, and Pharmacological Aspects, pp 3-55, Advances in Chemistry Series 198, American Chemical Society, Washington, DC.
172. Brinkley, M. (1992) A Brief Survey of Methods for Preparing Protein Conjugates with Dyes, Haptens, and CrossLinking Reagents. Bioconjugate Chem. 3, 2-13.
173. Lundblad, R. L., and Noyes, C. M. (1984) Chemical Reagents for Protein Modification, Vol. I and II, CRC Press, Inc., Boca Raton, FL.
174. Atassi, M. Z. (1977) Chemical Modification and Cleavage of Proteins and Chemical Strategy in Immunochemical Studies of Proteins. Immunochemistry of Proteins, Vol. 1, pp 1-161, Plenum Press, New York.
175. Cohen, L. A. (1968) Group-Specific Reagents in Protein Chemistry. Ann. Rev. Biochem. 37, 683-726.
176. Lundblad, R. L., and Noyes, C. M. (1984) Modification of Lysine. Chemical Reagents for Protein Modification. Vol. 1, pp 127-170, CRC Press, Inc., Boca Raton, FL.
177. Bodanszky, M. (1979) Active Esters in Peptide Synthesis. The Peptides. Analysis, Synthesis, Biology (E. Gross and J. Meienhofer, Eds.) Vol. 1, pp 105-196, Academic Press, Inc., Orlando, FL.
178. Bodanszky, M. (1984) Activation and Coupling. Principles of Peptide Synthesis, pp 9-58, Springer-Verlag, New York.
179. Blau, M., Johnson, A. C., and Pressman, D. (1958) p-Iodobenzoyl Groups as a Paired Label for in vivo Protein Distribution Studies: Specific Localization of Anti-tissue Antibodies. Int. J. Appl. Radiat. Isot. 3, 217-225.
180. Bolton, A. E., and Hunter, W. M. (1973) The Labeling of Proteins to High Specific Radioactivities by Conjugation to a 1-125 Containing Acylating Agent. Biochem. J. 133, 529-539.
181. Lucka, B., and Siuda, A. (1978) Preparation of Bolton and Hunter's Reagent for Labelling Proteins with Iodine-125. J. Labelled Compd. Radiopharm. 15, 495-497.
182. Langone, J. J. (1980) Radioiodination by Use of the Bolton-Hunter and Related Reagents. Methods Enzymol. 70, 221-243.
183. Langone, J. J. (1981) Radioiodination by Use of the Bolton-Hunter and Related Reagents. Methods Enzymol. 73, 113-127.
184. Katz, M. J., Lasek, R. J., Osdoby, P., Whittaker, J. R., and Caplan, A. I. (1982) Bolton-Hunter Reagent as a Vital Stain for Developing Systems. Dev. Biol. 90, 419-429.
185. Davies, G. E., and Palek, J. (1981) 125I-Labeling of Platelet Proteins with Bolton-Hunter Reagent. Anal. Biochem. 115, 383-387.
186. Thompson, J. A., Lau, A. L., and Cunningham, D. D. (1987) Selective Radiolabeling of Cell Surface Proteins to a High Specific Activity. Biochem. 26, 743-750.
187. Roger, S. (deceased), Los Alamos National Laboratory, private communication, unpublished results.
188. Knight, L. C., Harwig, S. S. L., and Welch, M. J. (1977) In Vitro Stability and In Vivo Clearance of Fibrinogen or Serum Albumin Labeled with 77Br, 131I, or 125I by Direct or Indirect Synthetic Methods. J. Nucl. Med. 18, 282-288.
189. Assoian, R. K., Blix, P. M., Rubenstein, A. H., and Tager, H. S. (1980) Iodotyrosylation of Peptides Using tertiary-Butyloxycarbonyl-L- [ 125I] Iodotyrosine N-Hydroxysuccinimide Ester. Anal. Biochem. 103, 70-76.
190. Wilbur, D. S., Rogers, R. S., and Svitra, Z. V. (1984) Radiolabeled Phenylalkanoic Acids for Protein Labeling. Investigation of Arylsilanes as Intermediates for Radiolabeled Phenylpropionic Acids and Acid Derivatives. Proceedings of 1984 International Chemical Congress of Pacific Basin Societies, Honolulu, Hawaii, Dec 16-21 (abstract).
191. Quick, A. J. (1932) The Relationship between Chemical Structure and Physiological Response. I. The Conjugation of Substituted Benzoic Acids. J. Biol. Chem. 96, 83-101.
192. Friedman, A. M., Zalutsky, M. R., Wung, W., Buckingham, F., Harper, P. V., Scherr, G. H., Wainer, B., Hunter, R. L., Appelman, E. H., Rothberg, R. M., Fitch, F. W., Stuart, F. P., and Simonian, S. J. (1977) Preparation of a Biologically Stable and Immunogenically competent Astatinated Protein. Int. J. Nucl. Med. Biol. 4, 219-224.
193. Vaughan, A. T. M. (1979) The Labeling of Proteins with 2UAt using an Acylation Reaction. Int. J. Appl. Radiat. Isot. 30, 576-577.
194. Harrison, A., and Royle, L. (1984) Preparation of a 2UAt-IgG Conjugate Which Is Stable in vivo. Int. J. Appl. Radiat. Isot. 35, 1005-1008.
195. Wilbur, D. S., Jones, D. S., and Fritzberg, A. R. (1986) Synthesis and Radioiodinations of Some Aryltin Compounds for Radiolabeling of Monoclonal Antibodies. J. Labelled Compd. Radiopharm. 23, 1304-1306 (abstract).
196. Hadley, S. W., Grant, L. M., and Wilbur, D. S. (1987) Evaluation of Radioiodinations and Conjugations of 4-Iodo-benzoates for Protein Labeling. J. Nucl. Med. 28, 725 (abstract).
197. Wilbur, D. S., Hadley, S. W., Grant, L. M., and Hylarides, M. D. (1991) Radioiodinated Iodobenzoyl Conjugates of a Monoclonal Antibody Fab Fragment. In Vivo Comparisons with Chloramine-T Labeled Fab. Bioconjugate Chem. 2, 111-116.
198. Badger, C. C., Wilbur, D. S., Hadley, S. W., Fritzberg, A. R., and Bernstein, I. D. (1990) Biodistribution of Para-Iodobenzoyl (PIP) Labeled Antibodies in a Murine Lymphoma Model. Nucl. Med. Biol. 17, 381-387.
199. Murray, J. L., Mujoo, K., Wilmanns, C., Mansfield, P., Wilbur, D. S., and Rosenblum, M. G. (1991) Variables Influencing Tumor Uptake of Antimelanoma Monoclonal Antibodies Radioiodinated Using the para-Iodophenyl (PIP) Technique. J. Nucl. Med. 32, 279-287.
200. Mujoo, K., Rosenblum, M. G., and Murray, J. L. (1991) Augmented Binding of Radiolabeled Monoclonal Antibodies to Melanoma Cells using Specific Antibody Combinations. Cancer Res. 51, 2768-2772.
201. Khawli, L. A., and Kassis, A. I. (1989) Synthesis of 126I Labeled N-succinimidylp-iodobenzoate for use in radiolabeling antibodies. Nucl. Med. Biol. 16, 727-733.
202. Wahl, R., Roberts, J., Hopkins, M., Dresschar, C., Fig, L., Mallette, S., Mudgett, E., Foisie, D., Schroff, D., Abrams, P., Fer, M., and Wilbur, S. (1990) Phase I Evaluation of 1-131 PIP Labeled Antiovarian Carcinoma Antibody. J. Nucl. Med. 31, 111 (abstract).
203. Nelp, W., University of Washington, unpublished data.
204. Zalutsky, M. R., and Narula, A. S. (1987) A Method for the Radiohalogenation of Proteins Resulting In Decreased Thyroid Uptake of Radioiodine. Int. J. Radiat. Appl. Inst. [A], 38, 1051-1055.
205. Zalutsky, M. R., and Narula, A. S. (1988) Radiohalogenation of a Monoclonal Antibody Using an N-Succinimidyl 3-(Tri-n-butylstannyl)benzoate Intermediate. Cancer Res. 8, 1446-1450.
206. Zalutsky, M. R., Noska, M. A., Colapinto, E. V., Garg, P. K., and Bigner, D. D. (1989) Enhanced Tumor Localization and in Vivo Stability of a Monoclonal Antibody Radioiodinated Using N-Succinimidyl 3-(Tri-n-butylstannyl)benzoate. Cancer Res. 49, 5543-5549.
207. Zalutsky, M. R., Garg, P. K., Friedman, H. S., and Bigner, D. D. (1989) Labeling monoclonal antibodies and F(ab'h fragments with the alpha emitting radionuclide astatine-211: Preservation of immunoreactivity and in p250 localizing capacity. Proc. Natl. Acad. Sci. U.S.A. 86, 7149-7153.
208. Garg, P. K., Slade, S. K., Harrison, C. L., and Zalutsky, M. R. (1989) Labeling Proteins Using Aryl Iodide Acylating Agents: Influence of Meta vs Para Substitution on In Vivo Stability. Nucl. Med. Biol. 16, 669-673.
209. Garg, P. K., Harrison, C. L., and Zalutsky, M. R. (1990) Comparative Tissue Distribution in Mice of the α-Emitter 2uAt and 131I as Labels of a Monoclonal Antibody and F(ab')2-Cancer Res. 50, 3514-3520.
210. Schuster, J. M., Garg, P. K., Bigner, D. D., and Zalutsky, M. R. (1991) Improved Therapeutic Efficacy of a Monoclonal Antibody Radioiodinated Using N-Succinimidyl 3-(Tri-n-butylstannyl)benzoate. Cancer Res. 51, 4164-4169.
211. Vaidyanathan, G., and Zalutsky, M. R. (1990) Protein Radiohalogenation: Observations on the Design of N-Suc-cinimidyl Ester Acylation Agents. Bioconjugate Chem. 1, 269-273.
212. Quadri, S. M., Zhang, Y.-Z., and Williams, J. R. (1991) Improvements in Radioiodination of Monoclonal Antibodies for Diagnosis and Treatment of Cancer. Antibody, Immunoconjugate Radiopharm. 4, 283-296.
213. Freud, A., Canfi, A., and Hirshfeld, N. (1991) N-Succin-imidyl-3-Iodo-(126I)-Benzoate. A new compound for protein iodination. J. Labelled Compd. Radiopharm. 30, 203-204 (abstract).
214. Shen, X., Hanson, R. N., and Elmaleh, D. R. (1991) Synthesis and Evaluation of Radioiodinated Tetrafluorophenyl m-Iodobenzoate and Tetrafluorophenyl-5-Iodopentenoates as Conjugating Agents for Proteins and Antibodies. J. Labelled Compd. Radiopharm. 30, 222-223 (abstract).
215. Vaidyanathan, G., and Zalutsky, M. R. (1992) Labeling of Proteins with Fluorine-18 Using N-Succinimidyl 4-[18F]-Fluorobenzoate. Nucl. Med. Biol. 19, 275-281.
216. Vaidyanathan, G., and Zalutsky, M. R. (1990) Radioiodination of Antibodies via N-Succinimidyl 2, 4-Dimethoxy-3-(trialkylstannyl)benzoates. Bioconjugate Chem. 1, 387-393.
217. Garg, S., Garg, P. K., and Zalutsky, M. R. (1991) N-Suc-cinimidyl 5-(Trialkylstannyl)-3-pyridinecarboxylates: A New Class of Reagents for Protein Radioiodination. Bioconjugate Chem. 2, 50-56.
218. Garg, S., Garg, P. K., Bigner, D. D., and Zalutsky, M. R. Radioiodination and Astatination of Monoclonal Antibodies Using Heterocyclic Acylation Reagents. J. Labelled Compd. Radiopharm. 30, 207-208 (abstract).
219. Vaidyanathan, G., Affleck, D. J., and Zalutsky, M. R. (1992) Radioiodination of Proteins using N-Succinimidyl 4-Hydroxy-3-Iodobenzoate. Proceedings of the 9th International Symposium on Radiopharmaceutical Chemistry; pp 378-380, Paris, France, Apr 6-10 (abstract).
220. Narula, A. S., and Zalutsky, M. R. (1988) Synthesis of N-Succinimidyl-2, 4-Dimethoxy-3-(Tri-n-butylstannyl)ben-zoate via Regio-specifically Generated Lithium 2, 4-Dimethoxy-3-lithiobenzoate. Tetrahedron Lett. 29, 4385-4388.
221. Riley, M., and Perham, R. N. (1973) The Reaction of Protein Amino Groups with Methyl 5-Iodopyridine-2-carbox-imidate. Biochem. J. 31, 625-635.
222. Hadley, S. W., and Wilbur, D. S. (1990) Evaluation of Iodovinyl Antibody Conjugates: Comparison with a p-Iodo-benzoyl Conjugate and Direct Radioiodination. Bioconjugate Chem. 2, 154-161.
223. Otto, C. A., Brown, L. E., and Scott, A. M. (1985) Radioiodinated Branched-Chain Fatty Acids: Substrates for Beta Oxidation? Concise Communication. J. Nucl. Med. 25, 75-80.
224. Demaison, L., Dubois, F., Apparu, M., Mathieu, J.-P., Vidal, M., Comet, M., and Cuchet, P. (1988) Myocardial Metabolism of Radioiodinated Methyl-Branched Fatty Acids. J. Nucl. Med. 29, 1230-1236.
225. Jacobson, K. A., Furlano, D. C., and Kirk, K. L. (1988) A Prosthetic Group for Rapid Introduction of Fluorine into Peptides and Functionalized Drugs. J. Fluorine Chem. 39, 339-347.
226. Garg, P. K., Garg, S., and Zalutsky, M. R. (1991) Fluorine-18 Labeling of Monoclonal Antibodies and Fragments with Preservation of Immunoreactivity. Bioconjugate Chem. 2, 44-49.
227. Herman, L. W., Elmaleh, D. R., Fischman, A. J., Hanson, R. J., and Strauss, H. W. (1991) The Use of Pentafluorophenyl Derivatives for the 18F Labeling of Proteins. J. Labelled Compd. Radiopharm. 30, 205-206 (abstract).
228. Zalutsky, M. R., Garg, P. K., Johnson, S. H., Utsunomiya, H., and Coleman, R. E. (1992) Fluorine-18-Antimyosin Monoclonal Antibody Fragments: Preliminary Investigations in a Canine Myocardial Infarct Model. J. Nucl. Med. 33, 575-580.
229. Hunter, M. J., and Ludwig, M. L. (1962) The Reaction of Imidoesters with Proteins and Related Small Molecules. J. Am. Chem. Soc. 84, 3491-3504.
230. Wood, F. T., Wu, M. M., and Gerhart, J. C. (1975) The Radioactive Labeling of Proteins with an Iodinated Amidi-nation Reagent. Anal. Biochem. 69, 339-349.
231. Tolan, D. R., Lambert, J. M., Boileau, G., Fanning, T. G., Kenny, J. W., Vassos, A., and Traut, R. R. (1980) Radioiodination of Microgram Quantities of Ribosomal Proteins from Polyacrylamide Gels. Anal. Biochem. 103, 101-109.
232. Praissman, M., Praissman, L., Kent, S. B., and Berkowitz, J. M. (1981) Preparation and Characterization of a Biologically Active Gastrin Derivative Modified with an 126I-Labeled Imidoester. Anal. Biochem. 115, 287-297.
233. Bright, G. R., and Spooner, B. S. (1983) Preparation and Reactions of an Iodinated Imidoester Reagent with Actin and α-Actinin. Anal. Biochem. 131, 301-311.
234. Weill, K. A., and Fitch, F. W. (1985) Cell Surface Modification with an Iodinatible Imidoester to Enhance Radiolabeling. J. Immunol. Meth 77, 1-8.
235. Kilbourn, M. R., Dence, C. S., Welch, M. J., and Mathieis, C. J. (1987) Fluorine-18 Labeling of Proteins. J. Nucl. Med. 28, 462-470.
236. Means, G.E., and Feeney, R. E. (1968) Reductive Alkylation of Amino Groups in Proteins. Biochemistry 7, 2192-2201.
237. Rice, R. H., and Means, G. E. (1971) Radioactive Labeling of Proteins in Vitro. J. Biol. Chem. 246, 831-832.
238. Tack, B. F., and Wilder, R. L. (1981) Tritiation of Proteins to High Specific Activity: Application to Radioimmunoassay. Methods Enzymol. 73, 138-147.
239. Jentoft, N., and Dearborn, D. G. (1979) Labeling of Proteins by Reductive Methylation Using Sodium Cyanoborohydride. J. Biol. Chem. 254, 4359-4365.
240. Su, S.-N., and Jeng, I. (1983) Conversion of a Primary Amine to a Labeled Secondary Amine by the Action of Phenolic Group and Radioiodination. Anal. Biochem. 128, 405-411.
241. Panuska, J. R., and Parker, C. W. (1987) Radioiodination of Proteins by Reductive Alkylation. Anal. Biochem. 160, 192-201.
242. Hylarides, M., Hadley, S. W., and Seubert, J., unpublished data, NeoRx Corp.
243. Satchell, D. P. N., and Satchell, R. J. (1975) Acylation vy Ketenes and Isocyanates. A Mechanistic Comparison. Chem. Soc. Rev. 4, 231-250.
244. Keana, J. F. W., and Mann, J. S. (1990) Chelating Ligands Functionalized for Facile Attachment to Biomolecules. A Convenient Route to 4-Isothiocyanatobenzyl Derivatives of Diethylenetriaminepentaacetic Acid and Ethylenediamine-tetraacetic Acid. J. Org. Chem. 55, 2868-2871.
245. Rana, T. M., and Meares, C. F. (1990) N-Terminal Modification of Immunoglobulin Polypeptide Chains Tagged with Isothiocyanato Chelates. Bioconjugate Chem. 1, 357-362.
246. Gansow, O. A. (1991) Newer Approaches to the Radiolabeling of Monoclonal Antibodies by Use of Metal Chelates. Nucl. Med. Biol. 18, 369-381.
247. Yuanfang, L., and Chuanchu, W. (1991) Radiolabeling of Monoclonal Antibodies with Metal Chelates. Pure Appl. Chem. 63, 427-463.
248. Dewanjee, M. K., Ghafouripour, A. K., Ganz, W., Serafini, A. N., and Sfakianakis, G. N. (1991) Radioiodination of Proteins by a New Conjugation Technique with Activated Para-methoxyphenylisothiocyanate. J. Labelled Compd. Radiopharm. 30, 328-329 (abstract).
249. Ram, S., and Buchbaum, D. J. (1992) Development of 3-Iodophenylisothiocyanate for Radioiodination of Monoclonal Antibodies. Appl. Radiat. Isotop. in press.
250. Ram, S., Fleming, E., and Buchsbaum, D. J. (1992) Development of radioiodinated 3-iodophenylisothiocyanate for coupling to monolonal antibodies. J. Nucl. Med. 33, 1029 (abstract).
251. Khawli, L. A., Chen, F.-M., Alauddin, M. M., and Epstein, A. L. (1991) Radioiodinated Monoclonal Antibody Conjugates: Synthesis and Comparative Evaluation. Antibody, Immunoconjugate Radiopharm. 4, 163-182.
252. Lundblad, R. L., and Noyes, C. M. (1984) The Modification of Cysteine. Chemical Reagents for Protein Modification. Vol. I, pp 55-93, CRC Press, Inc., Boca Raton, FL.
253. Lambert, J. M., Jue, R., and Traut, R. R. (1978) Disulfide Cross-Linking of Escherichia coli Ribosomal Proteins with 2-Iminothiolane (Methyl 4-Mercaptobutyrimidate): Evidence That the Cross-Linked Protein Pare are Formed in the Intact Ribosomal Subunit. Biochemistry, 17, 5406-5416.
254. Wower, I., Wower, J., Meinke, M., and Brimacombe, R. (1981) The Use of 2-iminothiolane as an RNA-protein crosslinking agent in Escherichia coli ribosomes, and the localization on 23S RNA of sites cross-linked to proteins L4, L6, L21, L23, L27, and L29. Nucleic Acids Res. 9, 4285-4302.
255. Ghosh, S. S., Kao, P. M., McCue, A. W., and Chappelle, H. L. (1990) Use of Maleimide-Thiol Coupling Chemistry for Efficient Syntheses of Oligonucleotide-Enzyme Conjugate Hybridization Probes. Bioconjugate Chem. 1, 71-76.
256. Birnbaumer, M. E., Schrader, W. T., and O'malley, B. W. Chemical Cross-Linking of Chick Oviduct Progesterone-Receptor Subunits by Using a Reversible Bifunctional CrossLinking Agent. Biochem. J. 181, 201-213.
257. Srivastava, P. C., Buchsbaum, D. J., Allred, J. F., Brubaker, P. G., Hanna, D. E., and Spicker, J. K. (1990) A New Conjugating Agent for Radioiodination of Protein: Low In Vivo Deiodination of a Radiolabeled Antibody in a Tumor Model. BioTechniques 8, 536-545.
258. Wilbur, D. S., Hylarides, M. D., Hadley, S. W., Schroeder, J., and Fritzberg, A. R. (1989) A General Approach to Radiohalogenation of Proteins. Radiohalogenation of Organometallic Intermediates Containing Protein Reactive Substituents. J. Labelled Compd. Radiopharm. 26, 316-318 (abstract).
259. Hargreaves, M. K., Pritchard, J. G., and Dave, H. R. (1970) Cyclic Carboxylic Monoimides. Chem. Rev. 70, 439-469.
260. Khawli, L. A., van den Abbeele, A. D., and Kassis, A. I. N-(m-[126I]Iodophenyl)maleimide: An Agent for High Yield Radiolabeling of Antibodies. Nucl. Med. Biol. 19, 289-295.
261. Hylarides, M. D., Wilbur, D. S., Reed, M. W., Hadley, S. W., Schroeder, J. R., and Grant, L. M. (1991) Preparation and in vivo Evaluation of an N-(p- [125I]Iodophenethyl)maleimide-Antibody Conjugate. Bioconjugate Chem. 2, 435-440.
262. Srivastava, P. C., Allred, J. F., Lambert, C. R., and Kennel, S. J. (1990) No-Carrier-Added Preparation of a New Radioiodinated Maleimide as a Potentially Attractive Radioimmu-noconjugator with Low in vivo Deiodination. J. Nucl. Med. 31, 906 (abstract).
263. Shuie, C.-Y., Wolf, A. P., and Hainfeld, J. F. (1989) Synthesis of 18F-Labelled N-(p-[18F]fluorophenyl)maleimide and its Derivatives for Labelling Monoclonal Antibody with 18F. J. Labelled Compd. Radiopharm. 26, 287-289 (abstract).
264. Holowka, D. (1981)N-Chloroacetyl-[126I]Iodotyramine: An Alkylating Agent with High Specific Activity. Anal. Biochem. 117, 390-397.
265. Wyeth, P., and Douglas, S. G. (1984) High Activity Antibody Radioiodination without Loss of Antigen Binding. Proceedings of the Fifth International Symposium on Radiopharmaceutical Chemistry, Tokyo, Japan, July 9-13, pp 100-101.
266. Hylarides, M. D., Wilbur, D. S., Schroeder, J. R., Grant, L. M., Seubert, J. R., Beaumier, P., and Fritzberg, A. R. (1988) Radioiodination of Monoclonal Antibodies. Labeling with Para-Iodophenyl (PIP) Derivatives using Protein Sulfhydryls. Clin. Nucl. Med. 13 (Suppl.) p 23 (abstract).
267. Smith, E. L., Hill, R. L., Lehman, I. R., Lefkowitz, R. J., Handler, P., and White, A. (1983) The Carbohydrates. Principles of Biochemistry: General Aspects. 7th ed., pp 96-105, McGraw-Hill Book Co., New York.
268. Day, E.D. (1990) The Secondary, Tertiary, and Quaternary Structures of Assembled Immunoglobulins. Advanced Immunochemistry. 2nd ed., pp 107-181, Wiley-Liss, New York.
269. Ohkura, T., Isobe, T., Yamashita, K., and Kobata, A. (1985) Structures of Carbohydrate Moieties of Two Monoclonal Human X-Type Immunoglobulin Light Chains. Biochemistry 24, 503-508.
270. Upeslacis, J., and Hinman, L. (1988) Chemical Modification of Antibodies for Cancer Chemotherapy. Annu. Rep. Med. Chem. 23, 151-160.
271. Rodwell, J. D., Alverez, V. L., Lee, C., Lopes, A. D., Goers, J. W. F., King, H. D., PowsneT, H. J., and McKearn, T. J. Site-Specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations. Proc. Natl. Acad. Sci. U.S.A. 83, 2632-2636.
272. Pittman, R. C., Carew, T. E., Glass, C. K., Green, S. R., Taylor, C. A., and Attie, A. D. (1983) A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem. J. 212, 791-800.
273. Slaunwhite, W. R. (1982) Ligand Compositions and Processes for Their Manufacture and Their Use in Radioimmunoassay. U.S. Patent 4, 358, 435.
274. Buckingham, J. (1969) The Chemistry of Arylhydrazones. Q. Rev. Chem. Soc. 23, 37-56.
275. Heindel, N. D., Van Dort, M., Cahn, M., Schneider, R., and Burns, H. D. (1985) The 1, 3, 4-Oxadiazole Moiety, A Protective Synthon for Indirect Radioiodination. J. Hetero-cycl. Chem. 22, 209-210.
276. Heindel, N. D., and Van Dort, M. (1985) Prosthetic Group Radioiodination at“No-Carrier-Added”Levels of Carbonyl-Containing Molecules. J. Org. Chem. 50, 1988-1990.
277. Rea, D. W., Ultee, M. E., Belinka, B. A., Coughlin, D. J., and Alvarez, V. L. (1990) Site-Specifically Radioiodinated Antibody for Targeting Tumors. Cancer Res. (Suppl.) 50, 857s-861s.
278. Belinka, B. A., Coughlin, D. J., and Alvarez, V. L. (1988) Radioiodinated site-specific monoclonal antibody conjugates for tumor therapy and imaging. Biochemistry 27, 3084 (abstract).
279. Randerath, K. (1981) 3-([3-126I]Iodo-4-hydroxyphenyl)-propionyl Carbohydrazide, a New Radioiodination Reagent for Ultrasensitive Detection and Determination of Periodate-Oxidized Nucleoside Derivatives and Other Carbonyl Compounds. Anal. Biochem. 115, 391-397.
280. Hylarides, M. D., Seubert, J., and Wilbur, D. S., NeoRx Corp., unpublished results.
281. Feliu, A. (1988) I. Preparation of [18F]p-Fluorophenyl-hydrazine using Diazonium Chemistry. II. A Radiolabelled Glucocorticoid: [18F] WIN 44577. Proceedings of the Seventh International Symposium on Radiopharmaceutical Chemistry, Groningen, The Netherlands, July 4-8, 1988.
282. Sandler, S. R., and Karo, W. (1972) Oximes. Organic Functional Group Preparations, Vol. 3, pp 365-405, Academic Press, New York.
283. Saunders, K. H., and Allen, R. L. M. (1985) Aromatic Diazo Compounds. 3rd ed., Edward Arnold (Publishers) Ltd., London, England.
284. Higgins, H. G., and Harrington, K. J. (1959) Reaction of Amino Acids and Proteins with Diazonium Compounds. II. Spectra of Protein Derivatives. Arch. Biochem. Biophys. 85, 409-425.
285. Wunderlich, G., Fischer, S., Dreyer, R., and Franke, W.-G. A Simple Method for Labelling Proteins with 2uAt via Diazotized Aromatic Diamine. J. Radioanal. Nucl. Chem., Lett. 117, 197-203.
286. Hayes, C. E., and Goldstein, I. J. (1975) Radioiodination of Sulfhydryl-Sensitive Proteins. Anal. Biochem. 67, 580-584.
287. Sears, D. A., Reed, C. F., and Helmkamp, R. W. (1971) A Radioactive Label for the Erythrocyte Membrane. Biochim. Biophys. Acta 233, 716-719.
288. De Jong, A. S. H., Bouma, J. M. W., and Gruber, M. (1981) 0-(4-Diazo-3, 5-di[126I] iodobenzoyl)sucrose, a novel radioactive label for determining organ sites of catabolism of plasma proteins. Biochem. J. 198, 45-51.
289. Chowdhry, V., and Westheimer, F. H. (1979) Photoaffinity Labeling of Biological Systems. Annu.Rev. Biochem. 48, 293-325.
290. Staros, J. V. (1980) Aryl azide photolabels in biochemistry. Trends Biochem. Sci. 320-322.
291. Isaacs, N. S. (1974) Carbenes (Methylenes). Reactive Intermediates in Organic Chemistry, pp 375-407, John Wiley & Sons, New York.
292. Pandey, R. N., Wilson, J. D., Zhao, X.-G., and Schlom, J. Photolabeling: A New Approach to Radioiodination. Antibody, Immunoconjugate Radiopharm. 4, 399-407.
293. Brunner, J., and Semenza, G. (1981) Selective Labeling of the Hydrophobic Core of Membranes with 3- (Trifluoromethyl) -3-(m-[125I]iodophenyldiazirine, a Carbene-Generating Reagent. Biochemistry 20, 7174-7182.
294. Frey, A. B., Kreibich, G., Washera, A., Clarke, L., and Waxman, D. J. (1986) 3-(Trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine Photolabels a Substrate-Binding Site of Rat Hepatic Cytochrome P-450 Form PB-4. Biochemistry 25, 4797-4803.
295. Brunner, J., Senn, H., and Richards, F. M. (1980) 3-Trifluoromethyl-3-phenyldiazirine. A New Carbene Generating Group for Photolabeling. J. Biol. Chem. 255, 3313-3318.
296. Baldini, G., Martoglio, B., Schachenmann, A., Zugliani, C., and Brunner, J. (1988) Mischarging Escherichia coli tRNAPhe with L-4'-[3-(Trifluoromethyl)-3H-diazirine-3-yl] -phenylalanine, a Photoactivatable Analogue of Phenylalanine. Biochemistry 27, 7951-7959.
297. Liu, M. T. H. (1987) Chemistry of Diazirines. Vols. I and II, CRC Press, Inc., Boca Raton, FL. Lundblad, R. L., and Noyes, C. M. (1984) The Chemical Cross-Linking of Peptide Chains. Chemical Reagents for Protein Modification. Vol. II, pp 123-139, CRC Press, Inc., Boca Raton, FL.
298. Peters, K., and Richards, F. M. (1977) Chemical Cross-Linking: Reagents and Problems in Studies of Membrane Structure. Annu. Rev. Biochem. 46, 523-551.
299. Das, M., and Fox, C. F. (1979) Chemical Cross-Linking in Biology. Annu. Rev. Biophys. Bioeng. 8, 165-193.
300. Tae, H. J. (1979) The Application of Chemical Crosslinking for Studies on Cell Membranes and Identification of Surface Reporters. Biochim. Biophys. Acta 559, 39-69.
301. Ji, I., and Ji, T. H. (1981) Both a and 6 subunits of human choriogonadotropin photoaffinity label the hormone receptor. Proc. Natl. Acad. Sci. U.S.A. 78, 5465-5469.
302. Schmitt, M., Painter, R. G., Jesaitis, A. J., Preissner, K., Sklar, L. A., and Cochrane, C. G. (1983) Photoaffinity Labeling of the N-Formyl Peptide Receptor Binding Site of Intact Human Polymorphonuclear Leukocytes. J. Biol. Chem. 258, 649-654.
303. Baenzinger, J. U., and Fiete, D. (1982) Photoactivatable Glycopeptide Reagents for Site-specific Labeling of Lectins. J. Biol. Chem. 257, 4421-4425.
304. Ji, T. H., and Ji, I. (1982) Macromolecular Photoaffinity Labeling with Radioactive Photoactivable Heterobifunctional Reagents. Anal. Biochem. 121, 286-289.
305. Ji, I., Shin, J., and Ji, T. H. (1985) Radioiodination of a Photoactivatable Heterobifunctional Reagent. Anal. Biochem. 151, 348-349.
306. Soundararajan, N., and Platz, M. S. (1990) Descriptive Photochemistry of Polyfluorinated Azide Derivatives of Methyl Benzoate. J. Org. Chem. 55, 2034-2044.
307. Shields, C. J., Chrisope, D. R., Schuster, G. B., Dixon, A. J., Poliakoff, M., and Turner, J. J. (1987) Photochemistry of Aryl Azides: Detection and Characterization of a Dehy-droazepine by Time-Resolved Infrared Spectroscopy and Flash Photolysis at Room Temperature. J. Am. Chem. Soc. 109, 4723-4726.
308. Schuster, G. B., and Liang, T. Y. (1987) Photochemistry of 3- and 4-Nitrophenyl Azides: Detection and Characterization of Reactive Intermediates. J. Am. Chem. Soc. 109, 7803-7810.
309. Crocker, P. J., Imai, N., Rajagopalan, K., Boggess, M. A., Kwiatkowski, S., Dwyer, L. D., Vanaman, T. C., and Watt, D. S. (1990) Heterobifunctional Cross-Linking Agents Incorporating Perfluorinated Aryl Azides. Bioconjugate Chem. 1, 419-424.
310. Keana, J. F. W., and Cai, S. X. (1990) New Reagents for Photoaffinity Labeling: Synthesis and Photolysis of Functionalized Perfluorophenyl Azides. J. Org. Chem. 55, 3640-3647.
311. Cai, S. X., Glenn, D. J., and Keana, J. F. W. (1992) Toward the Development of Radiolabeled Fluorophenyl Azide-Based Photolabeling Reagents: Synthesis and Iodinated 4-Azido-perfluorobenzoates and 4-Azido-3, 5, 6-trifluorobenzoates. J. Org. Chem. 57, 1299-1304.
312. Watt, D. S., Kawada, K., Leyva, E., and Platz, M. S. (1989) Exploratory photochemistry of iodinated aromatic azides. Tetrahedron Lett. 30, 899-902.
313. Dolder, M., Michel, H., and Segrist, H. (1990) 3-(Trifluoromethyl)-3-(m-Isothiocyanophenyl)diazirine: Synthesis and Chemical Characterization of a Heterobifunctional Carbene-Generating Cross-linking Reagent. J. Protein Chem. 9, 407-415.
314. Liberatore, F. A., Comeau, R. D., Mckearin, J. M., Pearson, D. A., Belonga, B. Q., Brocchini, S. J., Kath, J., Phillips, T., Oswell, K., and Lawton, R. G. (1990) Site-Directed Chemical Modification and Cross-Linking of a Monoclonal Antibody Using Equilibrium Transfer Alkylating Cross-Link Reagents. Bioconjugate Chem. 1, 36-50.
315. del Rosario, R. B., Wahl, R. L., Brocchini, S. J., Lawton, R. G., and Smith, R. H. (1990) Sulfhydryl Site-Specific CrossLinking and Labeling of Monoclonal Antibodies by a Fluorescent Equilibrium Transfer Alkylation Cross-Link Reagent. Bioconjugate Chem. 1, 51-59.
316. Lawton, R. G., and Mitra, S. (1979) Reagents for the CrossLinking of Proteins by Equilibrium Transfer Alkylation. J. Am. Chem. Soc. 101, 3097-3110.
317. Wilbur, D. S., Stray, J. E., Hamlin, D. K., Goffe, D. K., and Vessella, R. L. (1992) Synthesis and Radioiodination of an ETAC Reagent for Cross-Linking Antibody Fab'Fragments. J. Nucl. Med. 33, 943 (abstract).
318. Denny, J. B., and Blobel, G. (1984) 126I-labeledcrosslinking reagent that is hydrophilic, photoactivatable, and cleavable through an azo linkage. Proc. Natl. Acad. Sci. U.S.A. 81, 5286-5290.
319. Jaffe, C. L., Lis, H., and Sharon, N. (1980) New Cleavable Photoreactive Heterobifunctional Cross-Linking Reagents for Studying Membrane Organization. Biochemistry 19, 4423-4429.
320. Murphy, H. R., and Harris, H. W. (1987) Improved Synthesis and Iodination of a Cleavable Photoactivated Probe. Anal. Biochem. 165, 88-95.
321. Wollenweber, H.-W., and Morrison, D. C. (1985) Synthesis and Biochemical Characterization of a Photoactivatable, Iodinatable, Cleavable Bacterial Lipopolysaccharide Derivative. J. Biol. Chem. 260, 15068-15074.
322. Hidalgo, J. U., and Nadler, S. B. (1962) Stability Studies on I131-labeled Albumin. J. Nucl. Med. 3, 268-272.
323. Stern, P., Hagan, P., Halpern, S., Chen, A., David, G., Adams, T., Desmond, W., Brautigam, K., and Royston, I. (1982) The Effect of Radiolabel on the Kinetics of Monoclonal Anti-CEA in a Nude Mouse-Human Colon Tumor Model. Hy-bridomas in Cancer Diagnosis and Treatment (M. S. Mitchell, and H. F. Oettgen, Eds.) pp 245-253, Raven Press, New York.
324. Sands, H., and Jones, P. L. (1987) Methods for the Study of the Metabolism of Radiolabeled Monoclonal Antibodies by Liver and Tumor. J. Nucl. Med. 28, 390-398.
325. De Nardo, G. L., De Nardo, S. J., Miyao, N. P., Mills, S. L., Peng, J. S., O'nGrady, L. F., Epstein, A. L., and Young, W.C. (1988) Non-dehalogenation mechanisms for excretion of radioiodine after administration of labeled antibodies. Int.J. Biol. Markers 3, 1-9.
326. Axworthy, D. B., Wilbur, D. S., Schroff, R. W., Hadley, S. W., Hylarides, M. D., Collins, C., Nelp, W. B., and Fritzberg, A. R. (1988) Identification of the Major Urinary Metabolites of para-Iodobenzoate Conjugates of an Antibody Fragment in Humans: Comparison with Chloramine-T. J. Nucl. Med. 29, 1325 (abstract).
327. Axworthy, D. B., Vanderheyden, J. L., Wilbur, D. S., Hadley, S. W., Hylarides, M. D., Wahl, R. L., Hanelin, L., and Fritzberg, A. R. (1989) Urinary Metabolites of 1-131 and Re-186 Radiolabeled Conjugates of Monoclonal Antibodies and Fragments in Patients. J. Nucl. Med. 30, 793 (abstract).
328. Maack, T., Park, C.H., and Camargo.M.J.F. (1985) Renal Filtration, Transport, and Metabolism of Proteins. The Kidney, Physiology and Pathophysiology (D. W. Seldin and G. Giebisch, Eds.) pp 1733-1803, Raven Press, New York.
329. Kitteringham, N. R., Maggs, J. L., Newby, S., and Park, B. K. (1985) Drug-Protein Conjugates-VIII. The Metabolic Fate of the Dinitrophenyl Hapten Conjugated to Albumin. Biochem. Pharmacol. 34, 1763-1771.
330. Christie, G. Kitteringham, N. R., and Park, B. K. (1987) Drug-Protein Conjugates-XIII. The Disposition of the Ben-zylpenicilloyl Hapten Conjugated to Albumin. Biochem. Pharmacol. 36, 3379-3385.
331. Zunino, F., Giuliani, F., Savi, G., Dasdia, T., and Gambetta, R. (1982) Anti-Tumor Activity of Daunorubicin Linked to Poly-L-Aspartic Acid. Int. J. Cancer 30, 465-470.
332. Mueller, B. M., Wrasidlo, W. A., and Reisfeld, R. A. (1990) Antibody Conjugates with Morpholinodoxorubicin and Acid-Cleavable Linkers. Bioconjugate Chem. 1, 325-330.
333. Srinivasachar, K. and Neville, D. M. (1989) New Protein Cross-Linking Reagents That Are Cleaved by Mild Acid. Biochemistry 28, 2501-2509.
334. Marinez, O. and Wofsy, L. (1986) Immunotoxins. Handbook of Experimental Immunology, Vol.l: Immunochemistry, 4th ed. (D. M. Weir, Ed.) pp 37.1-37.11, Blackwell Scientific Publications, Oxford, England.
335. Trouet, A., Masquelier, M., Baurain, R., and Deprez-De Campeneere, D. (1982) A Covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as is required for a lysosomotropic drug-carrier conjugate: In vitro and in vivo studies. Proc. Natl. Acad. Sci. U.S.A. 79, 626-629.
336. Schroeder, J., Axworthy, D., Hadley, S. W., Hylarides, M. D., and Wilbur, D. S., unpublished results, NeoRx Corp. Goff, D. A., and Carroll, S. F. (1990) Substituted 2-Iminothiolanes: Reagents for the Preparation of Disulfide Cross-Linked Conjugates with Increased Stability. Bioconjugate Chem. 1, 381-386.
337. Greenfield, L., Bloch, W., and Moreland, M. (1990) Thiol-Containing Cross-Linking Agent with Enhanced Steric Hindrance. Bioconjugate Chem. 1, 400-410.
338. Hadley, S. M., Grant, L. M., Hylarides, M. D., Fritzberg, A. R., and Wilbur, D. S. (1989), Synthesis, Radioiodination, and Evaluation of a para-Iodobenzyl Alcohol Ester Antibody Conjugate. J. Nucl. Med. 30, 924 (abstract).
339. Haseman, M. K., Goodwin, D. A., Meares, C. F., Kaminski, M. S., Wensel, T. G., McCall, M. J., and Levy, R. (1986) Metabolizable mIn chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice. Eur. J. Nucl. Med. 12, 455-460.
340. Meares, C. F., McCall, M. J., Desphande, S. V., De Nardo, S. J., and Goodwin, D. A. (1988) Chelate Radiochemistry: Cleavable Linkers Lead to Altered Levels of Radioactivity in the Liver. Int. J. Cancer (Supplement) 2, 99-102.
341. Paik, C. H., Yokoyama, K., Reynolds, J. C., Quadri, S. M., Min, C. Y., Shin, S. Y., Maloney, P. J., Larson, S. M., and Reba, R. C. (1989) Reduction of Background Activities by Introduction of a Diester Linkage Between Antibody and a Chelate in Radioimmunodetection of Tumor. J. Nuc. Med. 30, 1693-1701.
342. Pittman, R. C., Carew, T. E., Glass, C. K., Green, S. R., Taylor, C. A., and Attie, A. D. (1983) A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo. Biochem. J. 212, 791-800.
343. Chaudhari, A. S., and Bishop, C. T. (1972) Coupling of Amino Acids and Amino Sugars with Cyanuric Chloride (2, 4, 6-Trichloro-s-triazine). Can. J. Chem. 50, 1987-1991.
344. Strobel, J. L., Baynes, J. W., and Thorpe, S. R. (1985) 125I-Glycoconjugate Labels for Identifying Sites of Protein Catabolism in vivo: Effect of Structure and Chemistry of Coupling to Protein on Label Entrapment in Cells after Protein Degradation. Arch. Biochem. Biophys. 240, 635-645.
345. Maxwell, J. L., Baynes, J. W., and Thorpe, S. R. (1988) Inulin-125I-Tyramine, an Improved Residualizing Label for Studies on Sites of Catabolism of Circulating Proteins. J. Biol. Chem. 263, 14122-14127.
346. Ali, S. A., Eary, J. F., Warren, S. D., Badger, C. C., and Krohn, K. A. (1988) Synthesis and Radioiodination of Tyramine Cellobiose for Labeling Monoclonal Antibodies. Nucl. Med. Biol. 15, 557-561.
347. Welch, M. J., Mathias, C. J., Moerlein, S. M., Connett, J. M., and Philpott, G. W. (1989) Tyramine-Cellobiose (TC) Labeling of Antibodies: A Comparison with Other Labeling Techniques. J. Labelled Compd. Radiopharm. 26, 269-270 (abstract).
348. Ali, S. A., Warren, S. D., Badger, C. C., Eary, J. F., Press, O. W., Krohn, K. A., and Nelp, W. B. (1989) Synthesis and Radioiodination of Aryl-Carbohydrate Compounds for Attachment to Monoclonal Antibodies. J. Labelled Compd. Radiopharm. 26, 319-321.
349. Ali, S. A., Warren, S. D., Richter, K. Y., Badger, C. C., Eary, J. F., Press, O. W., Krohn, K. A., Bernstein, I. D., and Nelp, W. B. (1990) Improving the Tumor Retention of Radioiodinated Antibody: Aryl Carbohydrate Adducts. Cancer Res. (Supplement) 50, 783s-788s.
350. Boeldt, E. J., Engelhardt, S., and Veleke, L. (1985) An Inexpensive Method for Monitoring Effluent Air from Iodination Hoods. Health Phys. 49, 1306-1307.
351. Ferens, J. M., Krohn, K. A., Beaumier, P. L., Brown, J. P., Hellstrom, I., Hellstrom, K. E., Carrasquillo, J. A., and Larson, S. M. (1984) High-Level Iodination of Monoclonal Antibody Fragments for Radiotherapy. J. Nucl. Med. 25, 367-370.
352. Weadock, K. S., Anderson, L. L., and Kassis, A. I. (1989) A Simple Remote System for the High-Level Radioiodination of Monoclonal Antibodies. J. Nucl. Med. Allied Sci. 33, 37-41.
353. Weadock, K. S., Sharkey, R. M., Varga, D. C., and Goldenberg, D. M. (1990) Evaluation of a Remote Radioiodination System for Radioimmunotherapy. J. Nucl. Med. 31, 508-511.